TPCW
EXAS

TD Private Client Wealth’s Exact Sciences EXAS Stock Holding History

TD Private Client Wealth’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16
Closed -$1.63K – 1687
2025
Q4 		$1.63K Buy
16
+1
+7% +$80 ﹤0.01% 1299
2025
Q3 		$821 Hold
15
– – ﹤0.01% 1366
2025
Q2 		$797 Buy
15
+9
+150% +$457 ﹤0.01% 1313
2025
Q1 		$260 Buy
+6
New +$304 ﹤0.01% 1370
2023
Q3 		– Sell
-12
Closed -$1.13K – 1236
2023
Q2 		$1.13K Hold
12
– – ﹤0.01% 1201
2023
Q1 		$814 Hold
12
– – ﹤0.01% 1203
2022
Q4 		$594 Buy
+12
New +$490 ﹤0.01% 1172
2021
Q4 		– Sell
-7
Closed -$668 – 1193
2021
Q3 		$668 Hold
7
– – ﹤0.01% 1142
2021
Q2 		$870 Hold
7
– – ﹤0.01% 1127
2021
Q1 		$922 Sell
7
-4
-36% -$548 ﹤0.01% 1079
2020
Q4 		$1.46K Hold
11
– – ﹤0.01% 980
2020
Q3 		$1.12K Hold
11
– – ﹤0.01% 953
2020
Q2 		$956 Buy
11
+7
+175% +$559 ﹤0.01% 966
2020
Q1 		$232 Sell
4
-12
-75% -$974 ﹤0.01% 1037
2019
Q4 		$1.48K Buy
+16
New +$1.41K ﹤0.01% 932

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

TD Private Client Wealth's EXAS Position: Q1 2026 in Review

TD Private Client Wealth sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 16 shares — an estimated $1.63K sold.

TD Private Client Wealth first reported a position in EXAS in Q4 2019 and held it in 15 quarters. The position peaked at $1.63K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • TD Private Client Wealth reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • TD Private Client Wealth sold 16 Exact Sciences shares in Q1 2026, an estimated $1.63K.
  • TD Private Client Wealth first reported a position in Exact Sciences in Q4 2019 and held it in 15 quarters.
  • TD Private Client Wealth's Exact Sciences position peaked at $1.63K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.